Exane Derivatives’s Vanguard FTSE Developed Markets ETF VEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,375
Closed -$117K 1084
2021
Q1
$117K Buy
+2,375
New +$116K 0.03% 401

Other funds holding VEA

Exane Derivatives's VEA Position: Q2 2021 in Review

Exane Derivatives sold out of Vanguard FTSE Developed Markets ETF (VEA) in Q2 2021, closing a stake of 2,375 shares — an estimated $117K sold.

Exane Derivatives first reported a position in VEA in Q1 2021 and held it in 1 quarter. The position peaked at $117K in Q1 2021. 1,557 funds tracked by Wall St. Rank hold VEA as of Q2 2021.

  • Exane Derivatives reported no remaining Vanguard FTSE Developed Markets ETF position as of Q2 2021 after selling out during the quarter.
  • Exane Derivatives sold 2,375 Vanguard FTSE Developed Markets ETF shares in Q2 2021, an estimated $117K.
  • Exane Derivatives first reported a position in Vanguard FTSE Developed Markets ETF in Q1 2021 and held it in 1 quarter.
  • Exane Derivatives's Vanguard FTSE Developed Markets ETF position peaked at $117K in Q1 2021.
  • 1,557 funds tracked by Wall St. Rank held Vanguard FTSE Developed Markets ETF as of Q2 2021.

Based on Exane Derivatives's 13F filing for Q2 2021, filed 28 Jul 2021.